OBJECTIVE: To study the relationship of leptin concentrations with indices of obesity, fasting insulin, insulin resistance and lipid pro®les (total cholesterol, low density lipoprotein (LDL)-cholesterol, high density lipoprotein (HDL)-cholesterol and triglyceride) in an Asian cohort. DESIGN: Cross sectional study. SUBJECTS: A total of 133 healthy volunteers were enrolled (64 female: age: 25 ± 61 y, body mass index (BMI): 18.7 ± 45.1 kgam 2 and 69 male: age: 25 ± 61 y, BMI: 19.3 ± 35.0 kgam 2 ). MEASUREMENTS: Weight, height, waist and hip circumferences, blood pressure, lean body mass (by bioelectric impedence analysis (BIA)), plasma leptin and lipid pro®les were taken after a 10 h fast. RESULTS: Percentage of body fat measured by bioelectric impedance was the strongest determinant of plasma leptin (r 0.844, P`0.0001). Females had higher leptin concentrations than males for the same fat mass. In a multiple linear regression model, body fat percentage, (percentage body fat * gender), hip circumference and fasting insulin were signi®cant determinants of leptin concentration (r 0.882, P`0.0001). CONCLUSION: Leptin concentration correlated closely with percentage body fat in Asian subjects. Hip circumference as a corollary for peripheral obesity, was better associated with leptin than waist circumference or waist-to-hip ratio (WHR). Distribution of fat in females tended to be peripheral and may partly explain the gender difference. Fasting insulin level and central obesity were correlated with HDL-cholesterol, triglyceride and blood pressure, while fasting leptin had little correlation with these metabolic parameters. Therefore, insulin resistance was a better guide to cardiovascular risk assessment than plasma leptin.
Introduction
Leptin (OB protein) has emerged in recent years as the long sought after`satiety hormone'. It is secreted exclusively by the adipocytes, in response to an increased fat mass (FM). The major site for action of leptin is in the ventro-medial hypothalamus where it decreases the biosynthesis and secretion of the neurotransmitter neuropeptide Y (NPY) ± a potent stimulator of appetite. 1 The obese obaob mouse has a congenital de®ciency of leptin due to a mutation in the ob gene. 2 Leptin administration to obaob and wildtype mice, induces loss of weight and fat tissue, by decreasing food intake and increasing energy expenditure. 3, 4 Similar experiments in obese dbadb mice failed to result in weight loss and fat reduction, because the problem is not leptin de®ciency, but that of defects in the leptin receptors or post-receptor signaling. 4 ± 6 In human beings, congenital leptin de®-ciency is rare and usually associated with severe early-onset obesity. 7, 8 However, the majority of studies have shown that the serum leptin concentration increases with the amount of adipose tissue in the body, 9 ± 14 suggesting decreased sensitivity to leptin.
The regulation of leptin production has not been clearly elucidated in humans. Insulin has been demonstrated to affect ob gene expression and stimulate leptin production in rats. 15 Leptin injections in obaob mice had a hypoglycaemic effect that was independent of reduced food intake or weight loss. 3 This hypoglycaemic action was accompanied by a proportionate reduction of circulating insulin concentration. 16 One explanation is that leptin increases insulin sensitivity of peripheral tissues in obaob mice resulting in an increased rate of glucose utilisation. Again these effects cannot be seen in dbadb mice upon leptin administration. 16 Human obesity is known to be associated with insulin resistance 17 and possibly with leptin resistance. The relationship and interaction between the two have not been fully elucidated. Some studies 10, 18 demonstrated positive correlation between leptin concentration and insulin resistance, while others did not ®nd such a relationship after correcting for body fat. 11,19 ± 21 The study was undertaken to determine i) the relationship of leptin concentration with indices of obesity in a group of Asian subjects, ii) the correlation of leptin concentration with fasting insulin and insulin resistance in non-diabetic individuals, and iii) the correlation of leptin concentration with lipid pro®le; speci®cally the triglyceride and high density lipoprotein (HDL) cholesterol levels which are affected by insulin resistance. 22 
Subjects and methods

Subjects
Subjects were volunteers, recruited through advertisements in local papers. A total of 133 volunteers with no past medical history were studied. They were seen after a 10 h fast and advised not to take any beverages containing alcohol or caffeine for 12 h prior to consultation. They were also asked to abstain from exercise and drinking excessive amounts of water in the 12 h prior to attendance at the clinic.
Methods
Anthropometric measurements were taken with the subjects in light clothing and without shoes. Height was measured with a wall-mounted stadiometer, (Voger and Halke, Hamburg, Germany) to the nearest 0.1 cm and weight was measured to the nearest 0.1 kg on a digital scale (SECA). Body mass index (BMI) was calculated by dividing weight (kg) by height 2 (m 2 ). Waist and hip circumferences were taken with a non-elastic tape measure. The waist was de®ned as the narrowest circumference between the costal margin and the iliac crest, and the hip was de®ned as the widest circumference between the waist and the thigh. 23, 24 Blood pressure was evaluated with a mercury sphygmomanometer in the left arm with the subject in a sitting position following a 5 min rest. Two readings were taken for each subject and the mean value used in analysis. Korotkov phase V was taken as the diastolic blood pressure.
Bioelectric impedence analysis (BIA) was performed with a SEAC Bioimpedence meter (UniQuest Ltd., model SFB3, Australia Queensland, St Lucia). This meter measures bioimpedence over the frequency range of 4 ± 1024 kHz, using the tetrapolar method. Fat free mass (FFM) was calculated according to the formula described by Lukaski et al. 25 Percentage body fat was derived from a two compartment model using the equation:
Venepuncture was performed at the end of the visit. Serum was collected for measurement of glucose, lipid pro®le and insulin, while plasma was collected for measurement of leptin.
Assays
The serum total cholesterol, triglyceride, HDL cholesterol and glucose were assayed by dry chemistry with the Kodak Ektachem Clinical Chemistry Slides and read on the Kodak Ektachem 700 analyser (Rochester, New York, USA) in the Biochemistry Department of the Singapore General Hospital. Methods used were glucose oxidase, O 2 electrode for glucose; cholesterol oxidase for total cholesterol; dextran sulphate and cholesterol oxidase for HDL and lipaseaglycerol kinase colorimetric method without glycerol correction for measurement of triglyceride, respectively.
The insulin assay was carried out using the Abbot IMX Insulin Assay (Abbot Laboratories Diagnostic Division, Dainabot, Tokyo, Japan), which is a Microparticle Enzyme Immunoassay. Insulin resistance was derived by homeostasis model assessment with the formula:
insulin resistance insulina22X5e
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Plasma leptin was measured by radioimmunoassay.
(RIA, Linco Research, St Charles, MO). Samples were assayed in duplicate. The interassay coef®cient of variation was 1.3% at 0.5 ngaml, 15.4% at 5.0 ngaml and 2.6% at 20 ngaml while the intraassay coef®cient of variation was 6.9%.
Statistical methods
Data were tested for normal distribution using the Kolmogorov-Smirnov test. Logarithmic transformation of variables was used to normalise data for weight, waist, FM, body fat percentage, leptin and triglyceride. Systolic and diastolic blood pressures, total cholesterol, low density lipoprotein (LDL)-cholesterol, HDL-cholesterol, waist-to-hip ratio (WHR), lean body mass, fasting glucose, fasting insulin and insulin resistance, could not be normalised by mathematical transformation. Parametric data were expressed as arithmetic mean AE standard deviation and non-parametric data as geometric mean and range. Comparisons between groups were done using the Student's t test and Mann-Whitney test, for parametric and non-parametric data, respectively. Relations between variables were determined using univariate and multiple linear regression (stepwise method). All analyses were two-tailed and a P-valuè 0.05 was considered statistically signi®cant. The statistical analyses were performed using SPSS 7.5 for Windows (SPSS Inc., Chicago, USA).
Results
Subjects' characteristics
Of the 133 individuals studied, 64 were female (age range: 25 ± 61 y and BMI range: 18.7 ± 45.1 kgam 2 ) and 69 were male (age range: 25 ± 61 y and BMI range: 19.3 ± 35.0 kgam 2 ). The racial distribution was 77.5% Chinese, 8.5% Indians, 3.5% Malays and 5.6% others. The characteristics of the male and female subjects are shown in Table 1 . Both male and female subjects were of similar age and BMI. Despite the similar levels of fasting insulin and insulin resistance, females had signi®cantly lower WHR, lower systolic and diastolic blood pressures, lower triglyceride levels and higher HDL cholesterol concentration than their male counterparts. Females were found to have signi®cantly higher percentage body fat and leptin concentrations.
Relationship of leptin concentration with various parameters
The univariate regression coef®cients of log. leptin concentration with various parameters for the two genders are shown in Table 2 . Obesity indices (percentage body fat, log.of FM, log.of BMI and log.of weight), fat distribution indices (log. of waist and hip circumference) and fasting insulin, were signi®cantly correlated with plasma leptin concentration. Blood pressures and lipid pro®les did not have any relationship with leptin concentrations.
Factors associated with log. leptin concentration
The interaction term (percentage body fat * gender) was introduced to examine the effect of gender on leptin concentration. In order to ascertain the effect and interaction of obesity, gender, fat distribution pattern and fasting insulin on plasma leptin, factors including percentage body fat, (percentage body fat * gender), hip circumference, log. waist, WHR, fasting insulin, were examined in a model using multiple linear regression stepwise method. 77.9% of variance in leptin was explained by a model including percentage body fat, (percentage body fat * gender) interaction term, fasting insulin and hip circumference (Table 3) .
Leptin, obesity and indices of fat distribution
Among the indices of obesity studied, percentage body fat was the best predictor of log. leptin concentration (r 0.70 and r 0.76 in males and females, respectively, P`0.0001) (Figure 1 ). Percentage body fat correlated best with hip circumference (r 0.543, Leptin and body fat in Asian subjects SC Ho et al P`0.01) followed by WHR (r 7 0.266, P`0.01).
The correlation of percentage body fat with waist was weak (r 0.180, P`0.05). To study the interaction between the three indices of fat distribution and body fat percentage, and to correct for their effects on leptin concentration, these three parameters were tested in multiple linear regression models with and without percentage body fat as the independent variable. In both models, hip circumference retained an independent and signi®cant association with log. leptin concentration, while waist and WHR were rejected ( Figure 2 ).
Leptin and blood pressure
Neither leptin concentration nor percentage body fat correlated signi®cantly with systolic and diastolic blood pressures. Instead, blood pressures were more closely linked to BMI and insulin resistance (Table 4) .
Leptin and insulin
The relationship of log. leptin concentration with fasting insulin and insulin resistance, remained signi®cant after controlling for body fat percentage. The partial correlation coef®cient of fasting insulin with log. leptin concentration were 0.30 in females and 0.34 in males (P`0.05) and that of insulin resistance with log. leptin concentration were 0.30 in females and 0.33 in males (P`0.05).
Leptin and lipids
Total cholesterol, LDL-cholesterol, triglyceride and HDL-cholesterol (in males only) were not correlated with log. leptin concentration. The relationship between HDL-cholesterol and log. leptin in female subjects, was signi®cant but weak and the correlation disappeared after adjusting for percentage body fat. Instead, parameters such as HDL-cholesterol and triglyceride were better correlated with fasting insulin Figure 1 Relationship of log leptin concentration with percentage body fat Figure 2 Relationship of log leptin concentration with hip circumference Table 4 Correlation coef®cient for systolic and diastolic blood pressure (BP) with insulin and anthropometric measurements Leptin and body fat in Asian subjects SC Ho et al level, BMI and WHR. Percentage body fat had little or no in¯uence on these variables (Table 5 ).
Discussion
The subjects in this study, though a random sample, were not representative of the general population in Singapore. The cohort, especially the female subjects, were generally more obese and had higher lipid levels than the general population in Singapore (1992 Singapore National Health Survey 27 ). The study population nevertheless included a wide range of BMIs and lipid concentrations. Considine et al 9 demonstrated elevated serum leptin concentrations in obese humans and that it was most closely correlated with the percentage body fat. Similar results were reported in subsequent studies. 10 ± 13,28 ± 31 Our study similarly showed that leptin concentrations were increased in obese Asian individuals and re¯ected the amount of adipose tissue in the body.
Obesity is known to be accompanied by insulin resistance. 17 Insulin resistance is, in turn, associated with increased insulin secretion to preserve normoglycaemia. As in previous studies, 10, 18 insulin resistance calculated by the homeostasis model assessment (HOMA model), 26 had a positive correlation with leptin even after adjusting for percentage body fat. The higher insulin concentration encountered in insulin resistance, may stimulate mRNA expression and hence increase the production of leptin in our body. This occurs in rats 15, 32 and has been demonstrated in humans by Kolaczynski et al. 33 However, several groups had not detected this relationship between leptin and insulin resistance 11,19 ± 21 and Vidal et al 34 did not demonstrate any change in the leptin mRNA of abdominal subcutaneous adipose tissue after insulin infusion. While insulin may directly affect leptin concentration, studies in obaob rats showed that leptin reduces insulin concentrations. 16 If obese humans are leptin resistant, this insulin lowering effect of leptin may be lost, resulting in a higher insulin concentration. Therefore, there is a possible role for leptin in hyperinsulinaemia or insulin resistance in human obesity. 35 Contrary to the report by Considine et al, 9 gender did exert an in¯uence on leptin concentration. Females have higher leptin concentrations than males at any level of adiposity. The interaction term (percentage body fat * gender) was a signi®cant and independent variable of log. leptin concentration in multiple regression model. This sexual dimorphism in plasma leptin concentration, had been previously demonstrated, but there has been no satisfactory explanation. 12, 13, 36, 37 Plasma leptin does not correlate with the concentration of sex steroids, 13, 14 nor does it correlate with fat distribution in some studies 12, 14, 38 which looked at waist, hip and WHR. We believe our data partially helps explain this sexual dimorphism. Hip circumference, not waist or WHR, has a signi®-cant association with plasma leptin in our multiple regression model. Hip circumference re¯ects gluteofemoral adipose tissue, a major component of peripheral obesity, whereas waist and WHR re¯ect centralaabdominal obesity. 39 This suggested that peripheral obesity was a stronger determinant of leptin concentration than central obesity. Ramachandran et al 30 examined central adiposity by computed tomography (CT) scan at L4 ± 5 levels, to show that subcutaneous and not visceral fat was a determinant of plasma leptin in Asian Indians. Leptin mRNA levels have also been found to be higher in subcutaneous adipocytes than the omental counterpart. 36, 40 Therefore, for a given level of adiposity, females have greater peripheral fat distribution, and hence more subcutaneous than visceral adipose tissue. The former produces more leptin, giving rise to the higher plasma leptin levels seen in women. Our ®ndings agreed with the results reported by Takahashi et al 31 and Lonnqvist et al. 41 Lipid pro®les (total cholesterol, HDL-cholesterol, LDL-cholesterol and triglyceride) and blood pressures are important in atherosclerosis and predict cardiovascular risk. 42 ± 45 In this study they were not affected by leptin concentration and instead correlated better with measures of visceral obesity, such as insulin resistance and WHR. We therefore hypothesize that insulin resistance and leptin resistance in obesity may have different metabolic consequences. The former, Leptin and body fat in Asian subjects SC Ho et al with its attendant central and visceral obesity, gives rise to atherogenic complications, while the latter is associated with the accumulation of peripheral fat, which is less relevant to cardiovascular risk.
Conclusion
The ®ndings in our study that serum leptin concentrations were higher in females and increased with obesity and insulin resistance concur with present knowledge. The observation that hip circumference, indicative of peripheral fat distribution, was associated with plasma leptin concentration, had not been demonstrated previously. Leptin concentration had no correlation with lipid pro®les and blood pressures. In contrast, the latter two variables were more closely linked to fasting insulin and central obesity. Therefore, insulin resistance with its accompanying central obesity would be a better guide to assessment of cardiovascular risk than possible leptin resistance.
